Association between dipeptidyl peptidase-4 inhibitors and urinary tract infection in elderly patients: A retrospective cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association between dipeptidyl peptidase-4 inhibitors and urinary tract infection in elderly patients: A retrospective cohort study

Published:2018-05-30 Issue:8 Volume:27 Page:931-939
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Imatoh Takuya¹^ORCID,Nishi Takumi²,Yasui Midori³,Maeda Toshiki⁴,Sai Kimie¹,Saito Yoshiro¹,Une Hiroshi⁵,Babazono Akira³

Affiliation:

1. Division of Medicinal Safety Science; National Institute of Health Sciences; Kawasaki-ku Kanagawa Japan

2. Department of Research Planning and Information Management; Fukuoka Institute of Health and Environmental Sciences; Dazaihu-city Japan

3. Department of Health Care Administration and Management, Graduate School of Medical Sciences; Kyushu University; Higashi-ku Fukuoka City Japan

4. Department of Preventive Medicine and Public Health; Fukuoka University; Jonan-ku Fukuoka City Japan

5. Department of Internal Medicine, Division of Preventive Medicine, Tenjin Clinic; Fukuoka City Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4560/fullpdf

Reference26 articles.

1. Safety of dipeptidyl peptidase 4 inhibitors: a perspective review;Karagiannis;Ther Adv Drug Saf,2014

2. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme;Matteucci;Curr Med Chem,2009

3. Role of CD26/dipeptidyl peptidase IV in human T cell activation and function;Ohnuma;Front Biosci,2008

4. The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes;Zhao;Diabetes Metab Res Rev,2014

5. Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase;Willemen;Diabetes Care,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT‐2 Inhibitor Use and Cause‐Specific Hospitalization Rates: An Outcome‐Wide Study to Identify Novel Associations of SGLT‐2 Inhibitors;Clinical Pharmacology & Therapeutics;2024-02-09

2. New-onset infective endocarditis in diabetic patients receiving SGLT2I, DPP4I and GLP1a: A population-based cohort study;2023-08-09

3. Association of the gallbladder or biliary diseases with dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: a meta-analysis of randomized controlled trials;Diabetology & Metabolic Syndrome;2022-10-21

4. The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis;Metabolites;2022-10-17

5. Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes;Diabetes & Metabolism;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3